Recently, huge (all-time high) volumes on this counter. Can’t find any bulk, or block trades either. Mixed Q3 FY24 results. Are the conditions in Angola getting better or something else?
Few developments:
- Raised capital through preferential allotment for capex – formulation plant. 32 Cr for phase-1 which will be completed in 1 year time. Funding secured for this.
- 15 Cr for phase-2 which will double phase-1 capacities. This will be secured by incremental preferential warrant issues.
- Incorporation of a step-down subsidiary in Chile and acquisition in Ecuador. Will help in expanding in South America.
Anyone tracking Balaxi Pharma?
| Subscribe To Our Free Newsletter |
